Frank McCormick Net Worth & Insider Trades

Frank McCormick - Director, Bridgebio Pharma, Inc

As of February 23, 2023

What is Frank McCormick's Net Worth?

The current estimated net worth of Bridgebio Pharma, Inc's Director, Frank McCormick, is estimated to be about $27.33M . Frank McCormick owns about 1,200,468 units of Bridgebio Pharma, Inc common stock. In the last 4 years at Bridgebio Pharma, Inc, Frank McCormick has sold an estimated value of $8.03M worth.

What is Frank McCormick's Past Insider Trading?

Frank McCormick's largest sale order was 100,000 units , worth over $4.28M on November 17, 2020. In total, Frank McCormick has made about 5 transactions over 4 years of their time at Bridgebio Pharma, Inc. Frank McCormick usually trades in May, December, July, February and November, with the busiest year in 2020 and 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!


Date Range: All Time
Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Frank McCormick's' Mailing Address?

  • Mailing address is C/o Exelixis Inc 170 Harbor Way S San Francisco CA 94083-0511 CA

Bridgebio Pharma, Inc Executive Compensation

Stock Awards
Option Awards
Other Compensation
Neil Kumar, Ph.D. 2020 $550,000 $825,000 $2,368,511 $6,299,998 $11,400 $10,054,909
Neil Kumar, Ph.D. 2019 $502,765 $360,000 $13,863,445 $11,573,049 $34,804 $26,334,063
Neil Kumar, Ph.D. 2018 $450,000 - - - - $450,000
Brian Stephenson, Ph.D., CFA 2020 $550,000 $712,500 $789,494 $2,099,996 $11,943 $4,163,933
Brian Stephenson, Ph.D., CFA 2019 $420,000 $189,000 $132,600 $3,430,781 $26,586 $4,198,967
Brian Stephenson, Ph.D., CFA 2018 $74,375 $330,240 $1,942,500 - - $2,347,115
Michael Henderson, M.D. 2020 $515,000 $300,000 $7,072,500 $91,899 $11,843 $7,991,241
Cameron Turtle, Ph.D.* 2020 $400,000 $210,000 $3,940,081 - $11,400 $4,561,482
Charles Homcy, M.D. 2020 $500,000 $100,000 - $1,199,992 $55,812 $1,855,805
Charles Homcy, M.D. 2019 $513,808 - $2,111,579 $3,128,716 $221,737 $5,975,842
Brian Stolz 2020 $511,362 $25,000 $736,854 $1,992,182 $1,975,453 $5,240,851
Brian Stolz 2019 $146,780 $93,750 $6,860,780 $1,045,003 - $8,146,313
No matching records found


What are Bridgebio Pharma, Inc's Past Insider Trades?

Bridgebio Pharma, Inc's most recent insider trade came on September 7, 2023 by Randal Scott who sold 2,500 units worth $75K . In the last 4 years, insiders at Bridgebio Pharma, Inc have sold an estimated value of $424.11M and bought an estimated value of $213.34M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Neil Kumar, CEO and President,  Brian C Stephenson, Secretary,  and Thomas Michael Henderson, Chief Business Officer .

BridgeBio Pharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found